Revisiting alginate paradigms

重新审视藻酸盐范式

基本信息

  • 批准号:
    10294953
  • 负责人:
  • 金额:
    $ 48.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-11-03 至 2023-10-31
  • 项目状态:
    已结题

项目摘要

Project Abstract This application seeks to define the molecular mechanisms and fitness benefits of alginate overproduction by mucoid variants of Pseudomonas aeruginosa. Specifically we will define features of the alginate biofilm matrix that enhance P. aeruginosa persistence and better understand the role of alginate in maintaining passive protection to the P. aeruginosa microbial community in the CF airway. This proposal will use state-of-the art molecular, biochemical, immunological, and genetic approaches to probe aspects of alginate pathogenesis and to reevaluate some long-standing paradigms. To date, the mechanisms underlying biofilm formation by alginate producing bacteria is not well understood. Aim 1 will investigate the biochemical and genetic basis for alginate biofilm matrix maintenance of biofilm integrity, structure, and antimicrobial resistance properties. While it is clear that mucoid variants predominate during chronic airway infection in CF patients, rarely are they present as pure clonal mucoid isolates. Instead, mucoid bacteria are typically associated with mixed populations of wild type P. aeruginosa that have not undergone mucoid conversion, as well as spontaneous suppressors that arise. The goal of Aim 2 is to test the hypothesis that this mixed consortia confers fitness benefits to the P. aeruginosa community as a whole that is not observed in either nonmucoid or mucoid bacteria alone. Alginate expression in the CF lung correlates with a poor clinical prognosis. However there are gaps in our knowledge regarding specific properties that alginate overproduction affords bacteria and the microbial consortia within the airway. The completion of these aims will lead to a deeper understanding of alginate biology and translate into novel therapies or interventions for CF patients colonized with mucoid P. aeruginosa.
项目摘要 该应用旨在通过以下方式定义藻酸盐过量生产的分子机制和健康益处: 铜绿假单胞菌的粘液变种。具体来说,我们将定义藻酸盐生物膜基质的特征 增强铜绿假单胞菌的持久性并更好地了解藻酸盐在维持被动性方面的作用 对 CF 气道中铜绿假单胞菌微生物群落的保护。 该提案将使用最先进的分子、生化、免疫学和遗传学方法来探索 藻酸盐发病机制的各个方面并重新评估一些长期存在的范式。迄今为止,机制 产生藻酸盐的细菌形成的潜在生物膜尚不清楚。目标 1 将调查 海藻酸盐生物膜基质维持生物膜完整性、结构和生物化学和遗传基础 抗微生物特性。虽然很明显粘液变体在慢性气道中占主导地位 CF 患者感染后,很少会以纯克隆粘液分离物的形式出现。相反,粘液细菌是 通常与未经过粘液处理的野生型铜绿假单胞菌混合种群相关 转换,以及出现的自发抑制。目标 2 的目标是检验以下假设: 混合菌群为整个铜绿假单胞菌群落带来了适应性益处,而这在 单独的非粘液或粘液细菌。 CF 肺中的藻酸盐表达与较差的临床表现相关 预后。然而,我们对海藻酸盐的具体特性的了解还存在空白。 过度生产会在呼吸道内产生细菌和微生物群落。这些目标的完成 将导致对藻酸盐生物学的更深入了解,并转化为 CF 的新疗法或干预措施 定植有粘液铜绿假单胞菌的患者。

项目成果

期刊论文数量(38)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dioxane-Linked Novel Bacterial Topoisomerase Inhibitors Exhibit Bactericidal Activity against Planktonic and Biofilm Staphylococcus aureus In Vitro.
  • DOI:
    10.1128/spectrum.02056-22
  • 发表时间:
    2022-12-21
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Chen, Anna;Dellos-Nolan, Sheri;Lu, Yanran;West, Jason S.;Wozniak, Daniel J.;Mitton-Fry, Mark J.
  • 通讯作者:
    Mitton-Fry, Mark J.
Mannose Conjugated Polymer Targeting P. aeruginosa Biofilms.
  • DOI:
    10.1021/acsinfecdis.0c00407
  • 发表时间:
    2020-11-13
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    Limqueco E;Passos Da Silva D;Reichhardt C;Su FY;Das D;Chen J;Srinivasan S;Convertine A;Skerrett SJ;Parsek MR;Stayton PS;Ratner DM
  • 通讯作者:
    Ratner DM
CdrA Interactions within the Pseudomonas aeruginosa Biofilm Matrix Safeguard It from Proteolysis and Promote Cellular Packing.
  • DOI:
    10.1128/mbio.01376-18
  • 发表时间:
    2018-09-25
  • 期刊:
  • 影响因子:
    6.4
  • 作者:
    Reichhardt C;Wong C;Passos da Silva D;Wozniak DJ;Parsek MR
  • 通讯作者:
    Parsek MR
Pseudomonas aeruginosa Initiates a Rapid and Specific Transcriptional Response during Surface Attachment.
  • DOI:
    10.1128/jb.00086-22
  • 发表时间:
    2022-05-17
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
  • 通讯作者:
The Pel polysaccharide is predominantly composed of a dimeric repeat of α-1,4 linked galactosamine and N-acetylgalactosamine.
  • DOI:
    10.1038/s42003-022-03453-2
  • 发表时间:
    2022-05-26
  • 期刊:
  • 影响因子:
    5.9
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Daniel J Wozniak其他文献

Daniel J Wozniak的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Daniel J Wozniak', 18)}}的其他基金

The impact of bacteriophage therapy on wound infection dynamics
噬菌体疗法对伤口感染动态的影响
  • 批准号:
    10467125
  • 财政年份:
    2022
  • 资助金额:
    $ 48.81万
  • 项目类别:
The impact of bacteriophage therapy on wound infection dynamics
噬菌体疗法对伤口感染动态的影响
  • 批准号:
    10560606
  • 财政年份:
    2022
  • 资助金额:
    $ 48.81万
  • 项目类别:
Revisiting alginate paradigms
重新审视藻酸盐范式
  • 批准号:
    10054154
  • 财政年份:
    2017
  • 资助金额:
    $ 48.81万
  • 项目类别:
Conserved complement binding to bacterial porins
与细菌孔蛋白结合的保守补体
  • 批准号:
    8772309
  • 财政年份:
    2014
  • 资助金额:
    $ 48.81万
  • 项目类别:
Pseudomonas biofilms and immunity
假单胞菌生物膜和免疫
  • 批准号:
    8978289
  • 财政年份:
    2013
  • 资助金额:
    $ 48.81万
  • 项目类别:
The essential P. aeruginosa pan-genome during chronic infection
慢性感染过程中必需的铜绿假单胞菌全基因组
  • 批准号:
    8623447
  • 财政年份:
    2013
  • 资助金额:
    $ 48.81万
  • 项目类别:
Pseudomonas biofilms and immunity
假单胞菌生物膜和免疫
  • 批准号:
    8601164
  • 财政年份:
    2013
  • 资助金额:
    $ 48.81万
  • 项目类别:
The essential P. aeruginosa pan-genome during chronic infection
慢性感染过程中必需的铜绿假单胞菌全基因组
  • 批准号:
    8780593
  • 财政年份:
    2013
  • 资助金额:
    $ 48.81万
  • 项目类别:
Pseudomonas biofilms and immunity
假单胞菌生物膜和免疫
  • 批准号:
    9188512
  • 财政年份:
    2013
  • 资助金额:
    $ 48.81万
  • 项目类别:
Pseudomonas biofilms and immunity
假单胞菌生物膜和免疫
  • 批准号:
    8506656
  • 财政年份:
    2013
  • 资助金额:
    $ 48.81万
  • 项目类别:

相似海外基金

Occurrence of antimicrobial resistance bacteria in wastewater of animal origin and its control by disinfection system combined with bacteriophage therapy
动物源性废水中耐药菌的产生及消毒系统联合噬菌体治疗的控制
  • 批准号:
    23K04097
  • 财政年份:
    2023
  • 资助金额:
    $ 48.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Fate of antimicrobial resistance genes in wastewater treatment processes focusing on their carrier bacteria and viruses.
废水处理过程中抗菌素耐药性基因的命运主要集中在其载体细菌和病毒上。
  • 批准号:
    23H01535
  • 财政年份:
    2023
  • 资助金额:
    $ 48.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Monitoring of antimicrobial resistance in bacteria of veterinary importance
监测具有兽医重要性的细菌的抗菌药物耐药性
  • 批准号:
    10828042
  • 财政年份:
    2023
  • 资助金额:
    $ 48.81万
  • 项目类别:
(Meta)genomics of bacteria and antimicrobial resistance from different food production systems
不同食品生产系统的细菌(元)基因组学和抗菌素耐药性
  • 批准号:
    2751064
  • 财政年份:
    2022
  • 资助金额:
    $ 48.81万
  • 项目类别:
    Studentship
Characterization of the antibacterial activity of some antimicrobial-derived metabolites and their involvement in the development of antimicrobial resistance in bacteria of animal origin
一些抗菌剂衍生代谢物的抗菌活性表征及其与动物源细菌抗菌素耐药性发展的关系
  • 批准号:
    RGPIN-2022-04264
  • 财政年份:
    2022
  • 资助金额:
    $ 48.81万
  • 项目类别:
    Discovery Grants Program - Individual
Characterization of the antibacterial activity of some antimicrobial-derived metabolites and their involvement in the development of antimicrobial resistance in bacteria of animal origin
一些抗菌剂衍生代谢物的抗菌活性表征及其与动物源细菌抗菌素耐药性发展的关系
  • 批准号:
    DGECR-2022-00286
  • 财政年份:
    2022
  • 资助金额:
    $ 48.81万
  • 项目类别:
    Discovery Launch Supplement
Prevalence of antimicrobial resistance genes among non-pathogenic bacteria population in the gut-microbiota
肠道微生物群中非致病菌群中抗菌素耐药性基因的流行率
  • 批准号:
    21K14994
  • 财政年份:
    2021
  • 资助金额:
    $ 48.81万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Use of bacteriophage therapy to control antimicrobial resistance bacteria during wastewater treatment
使用噬菌体疗法控制废水处理过程中的抗菌药物耐药菌
  • 批准号:
    20K14864
  • 财政年份:
    2020
  • 资助金额:
    $ 48.81万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Detection and surveillance of antimicrobial resistance among enteric bacteria from raw retail meat and seafood in Iowa: A NARMS Retail Food Surveillance Project
爱荷华州生零售肉类和海鲜中肠道细菌抗菌药物耐药性的检测和监测:NARMS 零售食品监测项目
  • 批准号:
    10477244
  • 财政年份:
    2020
  • 资助金额:
    $ 48.81万
  • 项目类别:
Detection and surveillance of antimicrobial resistance among enteric bacteria from raw retail meat and seafood in Iowa: A NARMS Retail Food Surveillance Project
爱荷华州生零售肉类和海鲜中肠道细菌抗菌药物耐药性的检测和监测:NARMS 零售食品监测项目
  • 批准号:
    10247550
  • 财政年份:
    2020
  • 资助金额:
    $ 48.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了